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A B S T R A C T
Objectives: This study aimed to review the single institutional experience of the repair of secundum atrial
septal defect (ASD) after the initiation of percutaneous trans-catheter device closure, to conﬁrm the
current management strategy and outcomes.
Methods: From August 2005 to December 2012, a total of 1026 (659 females, age 27  21 years)
consecutive patients underwent the repair of ASD. Including eight patients who converted to surgical repair,
317 patients (31%) underwent surgical repair and 709 (69%) underwent trans-catheter device closure.
Results: An embolized device into the left atrium was surgically retrieved in one patient soon after trans-
catheter device closure without any postoperative complications. The other patient developed left
atrium to aorta ﬁstula due to late erosion, and required the removal of implanted device and patch
closure of ﬁstula and ASD 3 months after trans-catheter device closure. Whereas serious central nerve
system complications occurred in three patients after the surgical repair including a 75-year-old patient
with postoperative transient atrial ﬁbrillation who subsequently developed aspiration pneumonia and
died; there were no mortalities and no morbidities associated with cranial nerve function after trans-
catheter device closure. A number of patients approached through partial sternotomy with limited skin
incision have increased per year, and the length of skin incision was 5.1  1.2 cm in pediatric patients
weighing less than 15 kg (n = 40), 6.9  1.9 cm in the remaining pediatric patients (n = 91), and 10.0  2.5 cm
in young adult females (n = 10).
Conclusion: Percutaneous trans-catheter ASD closure was safely performed under the support of a
surgical team. The cosmetic outcome of surgical closure is improving after initiation of partial
sternotomy via limited skin incision for the pediatric population and young adult females. Prior to the
treatment, the physicians must thoroughly inform patients and families of the advantages and
disadvantages of both treatment options.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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After a careful clinical trial, percutaneous trans-catheter device
closure of the ostium secundum atrial septal defect (ASD) with the
Amplatzer Septal Occluder (ASO, St. Jude Medical, St. Paul, MN,
USA) has been used in Japan since August 2005 and approved as a* Corresponding author at: 5-7-1, Fujishiro-dai, Suita, Osaka 565-8565, Japan.
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http://dx.doi.org/10.1016/j.jjcc.2014.07.009
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightshealth insurance treatment since March 2006 [1]. The number of
treated patients and licensed institutions has been increasing
recently [2–4], and most of the treated patients were evaluated
concerning trans-catheter ASD closure. Nowadays, the patients
who did not meet indications, or who indicated little risk of
insufﬁcient treatment and hesitated to receive it, underwent
surgical repair.
Although surgical repair of ASD is well known to involve
minimal complications, the advantage of trans-catheter device
closure is a less invasive approach [5]. Because trans-catheter
device closure can be done without a cardiopulmonary bypass,
cardioplegic arrest, thoracotomy, and sternotomy, it is completely reserved.
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bleeding, postsurgical inﬂammatory response syndrome, and
central nervous system damage. Moreover, its cosmetic superiority
is another attractive advantage for children and adult females. On
the contrary, late signiﬁcant complications could occur after trans-
catheter device closure, and outcomes of surgical closure required
after trans-catheter device closure are signiﬁcantly worse, as
opposed to that after primary surgical closure [4,6–11]. Therefore,
collaboration of cardiac catheter interventionists and surgeons is
more essential to treat patients with ASD in the current era.
This study aimed to review the clinical outcomes of repair of
ASD after percutaneous trans-catheter device closure was intro-
duced in order to conﬁrm the current management strategy and
outcomes.
Patients and methods
Patients
The National Cerebral and Cardiovascular Center Institutional
Review Board approved this retrospective study and waived the
need to obtain patient consent. From August 2005 to December
2012, a total of 1026 consecutive patients underwent the repair of
ASD in our center (Table 1). The diagnosis of ASD was mainly made
by transthoracic echocardiography, and the indication for device
closure was estimated by transesophageal echocardiography.
During the evaluation, patients whose other congenital heart
diseases were newly diagnosed, such as partial anomalous
pulmonary venous connection, unroofed coronary sinus, or cor
triatriatum, were excluded from this study.
Indication for trans-catheter device closure
The indications for percutaneous trans-catheter device closure
were well described [1–3]. Brieﬂy, a deﬁcient rim at inferior and/or
superior vena cava itself was not a contraindication for deploy-
ment; however, it was not indicated if sufﬁcient rim was not
presented at one-sixth or greater part of all circumferences.
Technical details of surgical repair
All surgical repairs were performed through median sternot-
omy. Pediatric patients were operated on by inferior median
sternotomy without splitting the presternum through limited skin
incision [12,13]. For teenage pediatric patients and adult female
patients, whose sternum was completely ossiﬁed, the sternal body
was divided toward the right side in a reverse L-shape with limited
skin incision. Bicaval venous cannulae and ascending aortic
cannula were inserted from the same operative ﬁeld for
establishment of cardiopulmonary bypass (CPB). The superior
vena cava was snared, but the inferior vena cava was not snared to
allow for better inspection of the posterior rim of ASD. Then the
aorta was cross-clamped, and antegrade cardioplegia was infused.
Electrical ventricular ﬁbrillation was not used, and the defect(s)
was closed directly, or with a fresh autopericardial patch. ATable 1
Patient characteristics.
Male:female (n) 367:659
Age [years, mean  SD (range)] 26.5  21.4 (0.5–80)
BW [kg, mean  SD (range)] 44.5  18.5 (4.8–112.6)
Qp/Qs [mean  SD (range)] 2.5  0.9 (0.8–5.6)
Diameter of ASD [mm, mean  SD (range)] 18  8 (2–60)
BW, body weight; Qp/Qs, pulmonary to systemic blood ﬂow ratio; ASD: atrial
septal defect.prophylactic right atrial cryoablation was added for all adult
patients over 20 years old.
Prior to the surgical procedure, autologous blood was not
pooled. Cardiopulmonary bypass was primed without a homolo-
gous blood transfusion for patients over 9 months old, and a blood
transfusion during cardiopulmonary bypass was indicated if the
hematocrit level decreased to less than 25% in patients below 9
months old, or decreased to less than 18% in patients over 9 months
old.
Study method
This was a retrospective, single-institutional cohort study. From
the patients’ catheter reports, operative records, and echocardiog-
raphy reports, the following variables were evaluated: the selected
treatments and trends of treated patients, outcomes in patients
undergoing percutaneous trans-catheter device closure, outcomes
in patients undergoing surgical repair, and a sub-group analysis
based on the age of patients undergoing surgical repair.
Sub-group outcomes, such as the prevalence of homologous
blood transfusion and the length of the skin incision, were
analyzed based on three different generations: Group A consisted
of pediatric patients under 20 years old with a body weight of less
than 15 kg; Group B, of pediatric patients under 20 years old with a
body weight of 15 kg or greater, and Group C, of adult patients over
20 years old.
Results
The trend of treatment selection
Of the 717 patients undergoing percutaneous trans-catheter
device closure, eight patients were converted to surgical repair
without deployment of devices due to technical difﬁculties, or
devices were once deployed but retrieved for fear of erosion at
aortic Valsalva wall. Finally, 709 patients (69%) underwent
percutaneous trans-catheter device closure and 317 patients
(31%) underwent surgical repair.
The number of treated patients and selected treatment method
were altered during the study period (Fig. 1). From 2005 to 2008,
both the number of patients undergoing percutaneous trans-
catheter device closure and those undergoing surgical closure had
increased each year. Since 2008, the number of patients undergo-
ing percutaneous trans-catheter device closure has been stabilized
to around 40 cases per year in children and 50 cases in adults
because of an increasing number of approved institutions for
percutaneous trans-catheter device closure. The number of
patients undergoing surgical closure has been also stabilized at
around 20 pediatric patients and 10 adult patients per year.
Outcomes in patients undergoing percutaneous trans-catheter device
closure
The characteristics of patients undergoing percutaneous trans-
catheter device closure are summarized in Table 2. Catheter
ablation for atrial ﬁbrillation was previously performed in nine
patients. Transluminal pulmonary valvuloplasty for pulmonary
stenosis or atresia was performed in 14 patients. As a concomitant
procedure, percutaneous device closure or coil embolization of the
patent ductus arteriosus was performed in four patients.
Complications after percutaneous trans-catheter ASD closure
are summarized in Table 3. There were no mortalities, thrombo-
embolic events, or pericardial effusions. A patient who developed
acute mitral regurgitation due to an embolization of the device into
the left atrium required emergent removal of the device and mitral
valve plasty without any postoperative complications. Another
Fig. 1. The number of treated patients and selected treatment in adult patients over 20 years (A), and pediatric patients under 20 years (B). The blue bars indicate trans-
catheter device closure, and the red bars indicate surgical closure. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
the article.)
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erosion of the device required surgical repair 3 months after trans-
catheter device closure, also without any complications or
sequelae.
Outcomes in patients undergoing surgical repair
The characteristics of patients undergoing surgical closure are
summarized in Table 4. Twenty patients (6.2%) and their families
preferred surgical repair regardless of an indication of trans-
catheter device closure. The diameter of ASD in patients treated
with surgery was bigger than trans-catheter device closure (trans-
catheter closure vs surgery: 2.3  0.8 vs 2.9  0.9, p < 0.001). Also,
estimated Qp/Qs in patients treated with surgery was larger than
trans-catheter device closure (trans-catheter closure vs surgery:
15  5 vs 26  10, p < 0.001).
Complications after surgical repair are summarized in Table 5.
Seventy-two-year-old males with postoperative transient atrial
ﬁbrillation who developed cerebral infarction 20 days after theTable 2
Characteristics of patients undergoing percutaneous trans-catheter device closure.
Male:female (n) 237:472
Age [years, mean  SD (range)] 28  20 (5–80)
Body weight [kg, mean  SD (range)] 48  16 (17–113)
Qp/Qs [mean  SD (range)] 2.3  0.8 (0.8–5.4)
Diameter of ASD [mm, mean  SD (range)] 15  5 (2–31)
Challenging cases (n) 144
Balloon size [mm, mean  SD (range)] 18  5 (6–34)
Device size [mm, mean  SD (range)] 19  5 (6–34)
Preceding procedure (n)
Catheter ablation for Aﬁb 9
PTPV for PS or PA 14
Concomitant procedure (n)
PTPV for PS 3
ADO 2
Coil embolization for PDA 2
ASD, atrial septal defect; Qp/Qs, pulmonary to systemic blood ﬂow ratio; Aﬁb,
atrial ﬁbrillation; PTPV, percutaneous transluminal pulmonary valvoplasty;
PS, pulmonary stenosis; PA, pulmonary atresia; ADO, Amplatzer ductal
occluder; PDA, patent ductus arteriosus.operation died due to subsequent aspiration pneumonia. The two
remaining patients developed cerebral infarction (a 10-year-old
and a 55-year-old female) and were free from recurrent arrhyth-
mia during the perioperative period or congenital or secondary
coagulation disorder. Seven patients needed permanent pacemak-
er implantation for persistent atrial ﬁbrillation despite undergoing
the Maze procedure. As minor complications, no patient had
residual leakage; four patients needed drainage for pericardial
effusion or pleural effusion, and one patient had a wound infection
requiring in-hospital treatment.
Outcomes after surgical repair according to generations
Surgical outcomes grouped by three different generations are
summarized in Table 6. In Group B, 136 of 139 patients (98%) were
free from homologous blood transfusion without preoperative
pooling of the patients’ own blood.
The number of patients operated on through partial or reverse
L-shaped sternotomy with limited skin incision increased by
surgical year (Fig. 2). In recent years, most patients under 20 yearsTable 3
Complications after percutaneous trans-catheter atrial septal defect closure
(N = 709).
Major complications (n)
Death 0
Embolizationb 1
Erosiona 1
Advanced AV block 0
Atrial ﬂutter 2
IE 0
Need emergent Op.b 1
Minor complications (n)
Residual leak 0
Transient arrhythmia 3
Migraine 7
Femoral AV ﬁstula (not indicated during surgical repair) 7
AV, atrio-ventricular; IE, infective endocarditis; Op., operation.
a Left atrium – aorta communication needed surgical repair.
b The same patient. Acute mitral regurgitation due to the embolization of the
device necessitating emergent operation.
Table 5
Complications after surgical repair (N = 317).
Major complications (n)
Deatha 1
Cerebral infarctiona 3
Permanent PMI 7
Atrial tachycardia 3
IE 0
Minor complications (n)
Residual leak 0
Transient arrhythmia 3
Pericardial effusion 2
Pleural effusion 2
Wound infection 1
PMI, pacemaker implantation; IE, infective
endocarditis.
a The same patient.
Table 4
Characteristics of patients undergoing surgical repair.
Male:female (n) 130:187
Age at Op. [years, mean  SD] 24  16 (0–76)
Body weight at Op. [kg, mean  SD] 20  18 (5–88)
Qp/Qs [mean  SD] 2.9  0.9 (1.5–5.6)
Diameter of ASD [mm, mean  SD] 26  10 (5–60)
ASO out of indication [n, (%)] 297 (93.7)
Patients’ preference [n, (%)] 20 (6.3)
Op., operation; Qp/Qs, pulmonary to systemic blood ﬂow ratio; ASD, atrial
septal defect; ASO, Amplatzer septal occluder.
Table 6
Outcomes after surgical repair by three different generations.
Group A B C
Number of patients 61 139 117
BW (kg) <15 15
Age (years) <20 <20 20
Homologous blood
transfusion [n, (%)]
10 (16.7) 3 (2.2) 26 (22.2)
Limited skin incision
[n, (%)]
40 (65.6) 91 (65.5) 10 (8.5)
Length of skin incision
(cm, mean  SD)
5.1  1.2 6.9  1.9 10.0  2.5
Skin incision/height ratio
(cm, mean  SD)
0.06  0.02 0.05  0.01 0.07  0.02
BW, body weight; SD, standard deviation.
T. Hoashi et al. / Journal of Cardiology 65 (2015) 418–422 421could undergo operation with limited skin incision and partial
inferior median sternotomy. Of all patients on whom partial median
sternotomy was attempted, only one patient with pectus excavatum
was converted to full sternotomy due to poor inspection of the
operative ﬁeld. In patients under 20 years, the mean length of the
skin incision was 5.1  1.2 cm and the skin incision/height ratio was
0.058  0.02 for patients under 15 kg, and 6.9  1.9 cm with a skin
incision/height ratio of 0.054  0.01 for patients over 15 kg.Fig. 2. Surgical approaches in pediatric patients with a body weight of less than 15 kg (A
sternotomy, the red bars indicate lower partial sternotomy, and the green bars indicate
ﬁgure legend, the reader is referred to the web version of the article.)Discussion
This study demonstrated the outcomes for repair of ASD in the
era of percutaneous device closure. Deployment of the device was
tentative or attempted but could not be achieved in the catheter
laboratory for eight of 715 patients (1.1%), who successfully
underwent a surgical closure. Only two of 709 patients (0.28%)
required surgical interventions after trans-catheter device closure,
both of which were safely done without any complications.
Surgical closure resulted in three postoperative cerebral infarction
cases (0.95%), including one mortality (0.32%) case. Recent
technical improvement enabled the surgery through limited skin
incision in response to current cosmetic demands from patients
and the parents, without homologous blood transfusion.
Mortality and serious morbidity rates after both trans-catheter
ASD closure with ASO and surgical closure are similarly low
[10,11], but what we learn from these large volume studies is that
both treatment options may not be completely safe. Although
technical complexity does not exist at surgical ASD closure,
complications related to open-heart surgery using cardiopulmo-
nary bypass could affect the outcomes. Irregular surface at), 15 kg or more (B), and adult patients over 20 years (C). The blue bars indicate full
 reverse L-shaped sternotomy. (For interpretation of the references to color in this
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stress, or bed rest, may cause thromboembolic events after open-
heart surgery. Except one of three patients who developed
postoperative cerebral infarction due to transient atrial ﬁbrillation
after surgical ASD closure, two remaining patients did not have
recurrent arrhythmia and also inherent coagulation disorder such
as protein S, C, antithrombin III deﬁciency, or antiphospholipid
syndrome.
On the other hand, our institution did not experience serious
complications after trans-catheter device closure, such as erosion
of aortic Valsalva, cardiac perforation, or late cardiac tamponade
[4,6–9]. These favorable outcomes were provided by the presence
of technically sophisticated cardiac catheter interventionists and
their careful selection of patients and devices. To avoid the erosion
of aortic Valsalva, which was known as the principal cause of death
after device closure, the rate of surgical ASD closure is still high in
our institution (31%), as opposed to current North American
experiences [8,10,11]. For the same reason, retrieval of devices
should not be hesitated when unexpected compression of aortic
Valsalva was observed even if the device was deployed following
careful preoperative evaluation. Indeed, of ﬁve patients whose
once deployed devices were retrieved in this study cohort, three
were for fear of erosion at aortic Valsalva, therefore only one
patient in 709 patients developed erosion of aortic Valsalva.
Otherwise, the procedure must be performed under the presence
of a congenital cardiac surgeon experienced in intra-cardiac
anatomy, in order to quickly retrieve the complications surgically
[6,7,9].
Technical safety and the possibility of heart surgery with simple
congenital cardiac defects in the pediatric population through full
sternotomy, partial lower sternotomy, or anterolateral thoracoto-
my via limited skin incisions have been already reported since the
1980s [12–15]. Although those technical modiﬁcations were
sometimes introduced as minimally invasive cardiac surgery,
congenital heart surgery using the cardiopulmonary bypass was a
much more invasive intervention even if it was performed through
a small skin incision. For this reason, patients and their families
had not paid much attention to the size and location of the skin
incision until recently. After the standardization of percutaneous
trans-catheter ASD, however, cosmetic demands signiﬁcantly
increased because most patients who spoke to surgeons were
disappointed that they expected to undergo catheter treatment but
could not, and focused extremely on the length and location of skin
incision.
The necessity of homologous blood transfusion is another
disadvantage of surgical ASD closure. Including the prevention of
viral infections or anaphylactic responses, recent studies revealed
the avoidance of perioperative homologous blood transfusion has a
merit to reduce postoperative morbidities [16,17]. Although 12% of
the patients in this study who underwent surgical ASD closure
required a homologous blood transfusion, the prevalence of
perioperative homologous blood transfusions decreased to less
than 3% if we excluded elderly adult patients with associated
cardiac lesions to be repaired and pediatric patients under
9 months old. Now, we think a body weight of 10 kg or more is
enough to avoid perioperative homologous blood transfusion in
pediatric to middle-aged adult patients.
Particularly for adult congenital heart disease patients, autho-
rized institutions conducting percutaneous trans-catheter devise
closures are increasing, which provides more patients with the
ability to undergo catheter intervention rather than surgical
closure [18]. Also, the indication of catheter intervention for
concomitant lesions like arrhythmia, heart valve disease, and
patent ductus arteriosus is spreading as shown in this study. Theavoidance of open-heart surgery seems to be beneﬁcial for
patients, if therapeutic effect is equally obtained and complications
seldom occur, as opposed to surgical treatment. Careful follow-up
should be continued to establish an accurate treatment guideline
in consideration of the safety and feasibility of both therapeutic
options.
Conclusion
Percutaneous trans-catheter ASD closure with ASO was safely
performed under the support of a surgical team. The cosmetic
outcome of surgical closure is improving after initiation of partial
sternotomy via limited skin incision for the pediatric population
and young adult females. Prior to the treatment, the physicians
must thoroughly inform patients and families of the advantages
and disadvantages of both treatment options.
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